HSBC Holdings’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $621K | Sell |
3,286
-1,749
| -35% | -$306K | ﹤0.01% | 2115 |
|
|
2025
Q4 | $858K | Buy |
+5,035
| New | +$772K | ﹤0.01% | 2025 |
|
|
2025
Q2 | – | Sell |
-2,378
| Closed | -$292K | – | 3125 |
|
|
2025
Q1 | $292K | Sell |
2,378
-493
| -17% | -$64.3K | ﹤0.01% | 2394 |
|
|
2024
Q4 | $354K | Buy |
2,871
+605
| +27% | +$71.3K | ﹤0.01% | 2394 |
|
|
2024
Q3 | $252K | Sell |
2,266
-43,078
| -95% | -$4.72M | ﹤0.01% | 2467 |
|
|
2024
Q2 | $4.89M | Buy |
45,344
+15,041
| +50% | +$1.65M | ﹤0.01% | 1064 |
|
|
2024
Q1 | $3.65M | Sell |
30,303
-18,814
| -38% | -$2.3M | ﹤0.01% | 1218 |
|
|
2023
Q4 | $5.99M | Buy |
49,117
+47,194
| +2,454% | +$5.89M | 0.01% | 1086 |
|
|
2023
Q3 | $249K | Buy |
+1,923
| New | +$256K | ﹤0.01% | 2307 |
|
|
2022
Q4 | – | Sell |
-4,187
| Closed | -$567K | – | 3106 |
|
|
2022
Q3 | $567K | Buy |
4,187
+846
| +25% | +$129K | ﹤0.01% | 2108 |
|
|
2022
Q2 | $523K | Buy |
+3,341
| New | +$514K | ﹤0.01% | 2302 |
|
|
2022
Q1 | – | Sell |
-9,050
| Closed | -$1.16M | – | 3365 |
|
|
2021
Q4 | $1.16M | Buy |
9,050
+1,865
| +26% | +$245K | ﹤0.01% | 1955 |
|
|
2021
Q3 | $937K | Buy |
7,185
+5,544
| +338% | +$838K | ﹤0.01% | 1920 |
|
|
2021
Q2 | $291K | Sell |
1,641
-204
| -11% | -$35.3K | ﹤0.01% | 2540 |
|
|
2021
Q1 | $306K | Buy |
+1,845
| New | +$304K | ﹤0.01% | 2281 |
|
|
2020
Q4 | – | Sell |
-21,578
| Closed | -$3.1M | – | 3087 |
|
|
2020
Q3 | $3.1M | Buy |
21,578
+16,542
| +328% | +$2.05M | ﹤0.01% | 1131 |
|
|
2020
Q2 | $556K | Buy |
+5,036
| New | +$557K | ﹤0.01% | 1773 |
|
|
2020
Q1 | – | Sell |
-43,727
| Closed | -$6.53M | – | 2862 |
|
|
2019
Q4 | $6.53M | Buy |
43,727
+39,157
| +857% | +$5.33M | 0.01% | 1002 |
|
|
2019
Q3 | $586K | Sell |
4,570
-1,430
| -24% | -$192K | ﹤0.01% | 2237 |
|
|
2019
Q2 | $855K | Sell |
6,000
-26,232
| -81% | -$3.53M | ﹤0.01% | 1843 |
|
|
2019
Q1 | $4.61M | Sell |
32,232
-24,615
| -43% | -$3.21M | 0.01% | 1155 |
|
|
2018
Q4 | $7.05M | Buy |
56,847
+3,521
| +7% | +$522K | 0.01% | 979 |
|
|
2018
Q3 | $8.97M | Buy |
+53,326
| New | +$9.17M | 0.01% | 901 |
|
|
2018
Q1 | – | Sell |
-6,567
| Closed | -$884K | – | 2571 |
|
|
2017
Q4 | $884K | Buy |
6,567
+316
| +5% | +$43.8K | ﹤0.01% | 1322 |
|
|
2017
Q3 | $914K | Sell |
6,251
-566
| -8% | -$85.6K | ﹤0.01% | 1509 |
|
|
2017
Q2 | $1.06M | Sell |
6,817
-417
| -6% | -$63.8K | ﹤0.01% | 1447 |
|
|
2017
Q1 | $1.05M | Sell |
7,234
-822
| -10% | -$107K | ﹤0.01% | 1397 |
|
|
2016
Q4 | $878K | Sell |
8,056
-387
| -5% | -$43.1K | ﹤0.01% | 1470 |
|
|
2016
Q3 | $1.03M | Buy |
8,443
+1,635
| +24% | +$220K | ﹤0.01% | 1345 |
|
|
2016
Q2 | $962K | Sell |
6,808
-21,984
| -76% | -$3.24M | ﹤0.01% | 1360 |
|
|
2016
Q1 | $3.76M | Sell |
28,792
-2,351
| -8% | -$293K | 0.01% | 980 |
|
|
2015
Q4 | $4.38M | Sell |
31,143
-4,500
| -13% | -$624K | 0.01% | 991 |
|
|
2015
Q3 | $4.73M | Sell |
35,643
-6,085
| -15% | -$1.05M | 0.01% | 834 |
|
|
2015
Q2 | $7.35M | Buy |
41,728
+23,426
| +128% | +$4.21M | 0.02% | 714 |
|
|
2015
Q1 | $3.16M | Buy |
18,302
+3,940
| +27% | +$676K | 0.01% | 1056 |
|
|
2014
Q4 | $2.35M | Buy |
14,362
+11,890
| +481% | +$1.97M | ﹤0.01% | 1119 |
|
|
2014
Q3 | $397K | Buy |
2,472
+1,043
| +73% | +$160K | ﹤0.01% | 1515 |
|
|
2014
Q2 | $210K | Sell |
1,429
-171
| -11% | -$23.7K | ﹤0.01% | 1683 |
|
|
2014
Q1 | $222K | Buy |
+1,600
| New | +$241K | ﹤0.01% | 1608 |
|
Other funds holding JAZZ
VPM
VCM
EC
HSBC Holdings's JAZZ Position: Q1 2026 in Review
HSBC Holdings reduced its Jazz Pharmaceuticals (JAZZ) stake by 35% in Q1 2026, selling an estimated $306K and leaving 3,286 shares worth $621K. The position accounts for ﹤0.01% of the portfolio, ranked #2115.
HSBC Holdings first reported a position in JAZZ in Q1 2014 and has held it in 39 quarters since. The position peaked at $8.97M in Q3 2018. 570 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.
- HSBC Holdings held 3,286 shares of Jazz Pharmaceuticals worth $621K as of Q1 2026.
- HSBC Holdings sold 1,749 Jazz Pharmaceuticals shares in Q1 2026, an estimated $306K.
- Jazz Pharmaceuticals made up ﹤0.01% of HSBC Holdings's portfolio in Q1 2026, its #2115 holding.
- HSBC Holdings first reported a position in Jazz Pharmaceuticals in Q1 2014 and has held it in 39 quarters since.
- HSBC Holdings's Jazz Pharmaceuticals position peaked at $8.97M in Q3 2018.
- 570 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.
Based on HSBC Holdings's 13F filing for Q1 2026, filed 30 Apr 2026.